During the past decade, Policlinico Monteluce conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Monteluce" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "AGC Biologics S.p.A." with 1 trials sponsored, "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 1 trials sponsored and "Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Monteluce" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Monteluce" are "Leukemia" (4 trials), "Breast Cancer" (2 trials), "Lymphoma" (2 trials), "Diabetic Nephropathies" (1 trials) and "Hematological Malignancies" (1 trials). Many other conditions were trialed in "Policlinico Monteluce" in a lesser frequency.

Most popular intervention types in "Policlinico Monteluce" are "Drug" (11 trials), "Radiation" (5 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (5 trials), "cyclophosphamide" (4 trials), "allogeneic bone marrow transplantation" (3 trials), "autologous bone marrow transplantation" (3 trials) and "cytarabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Monteluce" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Policlinico Monteluce". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Policlinico Monteluce, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Monteluce, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".